SCHEMBL19429151

SCHEMBL19429151

C[S+]([O-])c1ccccc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.41
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP2A6 P11509 2/20 0.39
HPGD P15428 1/20 0.39
BCL2L1 Q07817 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR7 P34969 4/20 0.36
BACE1 P56817 1/20 0.36
DPP4 P27487 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
HDAC4 P56524 1/20 0.34
HDAC2 Q92769 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28061206 0.84 PTGS2 (0.36) PTGS2ALDH1A1HSD17B10CYP2A6HPGD
SCHEMBL23605424 0.83 MAPK1 (0.44) PTGS2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL19239136 0.79 TAAR1 (0.46) KMT2AHTR7HTR1A
SCHEMBL25905318 0.79 PTPRC (0.42) ALDH1A1HPGDMAPK1TDP1
SCHEMBL21225981 0.78 HTR1A (0.39) PTGS2HTR7HTR1A
SCHEMBL24588640 0.78 HTR1A (0.36) PTGS2HTR7HTR1A
SCHEMBL29730561 0.78 CYP2A6 (0.34) PTGS2CYP2A6
SCHEMBL24510852 0.78 CYP2A6 (0.34) PTGS2CYP2A6
SCHEMBL31717639 0.77 ALDH1A1 (0.44) PTGS2ALDH1A1HSD17B10CYP2A6HPGD
SCHEMBL31717550 0.77 ALDH1A1 (0.44) PTGS2ALDH1A1HSD17B10CYP2A6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119977939-A Synthesis method of 1, 9-dihalogenated dibenzothiophene derivative 西安欧得光电材料有限公司 2025-05-13 CN disclosed
WO-2023222909-A1 METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS Institut National de la Santé et de la Recherche Médicale (FR) 2023-11-23 WO disclosed
US-20230157160-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2023-05-18 US disclosed
US-11552253-B2 Compound for organic electric device, organic electric device using same, and electronic device DUK SAN NEOLUX CO., LTD. (KR) 2023-01-10 US disclosed
US-20210380568-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-12-09 US disclosed
CN-107428938-B Polyarylene sulfide resin and method for producing same, and poly (arylsulfonium salt) and method for producing same DIC株式会社 2021-01-15 CN disclosed
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380568-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, VDAC2 PTGS2 1506/4885ALDH1A1 1275/4885HSD17B10 2348/4885
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF OCIAD1, GPX1, PIEZO1 PTGS2 3262/4885ALDH1A1 453/4885HSD17B10 2437/4885
US-11552253-B2 Compound for organic electric device, organic electric device using same, and electronic device OR10J3, OR51E2, ORAI2 PTGS2 3523/4885ALDH1A1 999/4885HSD17B10 2454/4885
US-20230157160-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE OR10J3, OR51E2, ORAI2 PTGS2 3790/4885ALDH1A1 1082/4885HSD17B10 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.